Literature DB >> 22610240

DOCKing innate to adaptive signaling for persistent antibody production.

Markus Werner, Hassan Jumaa.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22610240     DOI： 10.1038/ni.2317

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  11 in total

Review 1.  Antigen-specific memory B cell development.

Authors:  Louise J McHeyzer-Williams; Michael G McHeyzer-Williams
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 2.  GEF what? Dock180 and related proteins help Rac to polarize cells in new ways.

Authors:  Jean-François Côté; Kristiina Vuori
Journal:  Trends Cell Biol       Date:  2007-08-31       Impact factor: 20.808

Review 3.  The regulation of immunoglobulin E class-switch recombination.

Authors:  Raif S Geha; Haifa H Jabara; Scott R Brodeur
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

4.  Stat3 activation by Src induces specific gene regulation and is required for cell transformation.

Authors:  J Turkson; T Bowman; R Garcia; E Caldenhoven; R P De Groot; R Jove
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 5.  Molecular mechanism of class switch recombination: linkage with somatic hypermutation.

Authors:  Tasuku Honjo; Kazuo Kinoshita; Masamichi Muramatsu
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling.

Authors:  Jean-François Côté; Andrea B Motoyama; Jason A Bush; Kristiina Vuori
Journal:  Nat Cell Biol       Date:  2005-07-17       Impact factor: 28.824

7.  STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress.

Authors:  Fatih M Uckun; Sanjive Qazi; Hong Ma; Lisa Tuel-Ahlgren; Zahide Ozer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-29       Impact factor: 11.205

8.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

9.  Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production.

Authors:  Katrina L Randall; Teresa Lambe; Andy L Johnson; Andy Johnson; Bebhinn Treanor; Edyta Kucharska; Heather Domaschenz; Belinda Whittle; Lina E Tze; Anselm Enders; Tanya L Crockford; Tiphaine Bouriez-Jones; Duncan Alston; Jason G Cyster; Michael J Lenardo; Fabienne Mackay; Elissa K Deenick; Stuart G Tangye; Tyani D Chan; Tahra Camidge; Robert Brink; Carola G Vinuesa; Facundo D Batista; Richard J Cornall; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

10.  DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Authors:  Haifa H Jabara; Douglas R McDonald; Erin Janssen; Michel J Massaad; Narayanaswamy Ramesh; Arturo Borzutzky; Ingrid Rauter; Halli Benson; Lynda Schneider; Sachin Baxi; Mike Recher; Luigi D Notarangelo; Rima Wakim; Ghassan Dbaibo; Majed Dasouki; Waleed Al-Herz; Isil Barlan; Safa Baris; Necil Kutukculer; Hans D Ochs; Alessandro Plebani; Maria Kanariou; Gerard Lefranc; Ismail Reisli; Katherine A Fitzgerald; Douglas Golenbock; John Manis; Sevgi Keles; Reuben Ceja; Talal A Chatila; Raif S Geha
Journal:  Nat Immunol       Date:  2012-05-13       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.